Hao Qi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hao Qi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Run-Guang Sun
College of Physics and Information Technology, Shaanxi Normal University, Xi'an, Shaanxi, People's Republic of China
3 shared publicationsWen-Fang Chen
3 shared publicationsYing Liu
3 shared publicationsKun Zhang
1 shared publicationShu-Rui Wang
1 shared publicationTing Bu
1 shared publication
Latest Publications
- Open Access
- 1 January 2012
- Published by AEPress, s.r.o. in General Physiology and Biophysics
- Vol. 31 (1) , 1-10
Biologic effects of SMF and paclitaxel on K562 human leukemia cells
Biologic effects of SMF and paclitaxel on K562 human leukemia cells
- 1 January 2012
- Published by AEPress, s.r.o. in General Physiology and Biophysics
- Vol. 31 (1) , 1-10
Open AccessBiologic effects of SMF and paclitaxel on K562 human leukemia cells
Biologic effects of SMF and paclitaxel on K562 human leukemia cells
- 27 July 2011
- Vol. 97 (2011May-Ju) , 386-92
An investigation into the combined effect of static magnetic fields and different anticancer drugs on K562 cell membranes
Cell membranes were shown to be sensitive to and affected by static magnetic fields (SMF). Cells were treated with four anticancer drugs followed by treatment with a combination of drugs and SMF. Individual cells were examined using atomic force microscopy (AFM). The drugs were taxol (alkaloid), doxorubicin (anthracycline), cisplatin (platinum compound) and cyclophosphamide (alkylating agent). Holes were observed in cells exposed to SMF but not in control groups. The number, size and shape of the holes were dependent on the drug type, SMF parameters and the duration of exposure. The results suggest that the application of a SMF could alter membrane permeability, increasing the flow of the anticancer drugs. This may be one of the reasons why SMF can strengthen the effect of anticancer drugs. Observations were also made of the effect of using different anticancer drugs. For example, the effect of SMF combined with taxol or cyclophosphamide on the cells was additive while the effect of SMF combined with cisplatin or doxorubicin was synergistic. The target sites of cisplatin and doxorubicin are nucleic acids; continued research is required into this important area to ascertain the effect of SMF on nucleic acids.
- 27 July 2011
- Vol. 97 (2011May-Ju) , 386-92
An investigation into the combined effect of static magnetic fields and different anticancer drugs on K562 cell membranes
Cell membranes were shown to be sensitive to and affected by static magnetic fields (SMF). Cells were treated with four anticancer drugs followed by treatment with a combination of drugs and SMF. Individual cells were examined using atomic force microscopy (AFM). The drugs were taxol (alkaloid), doxorubicin (anthracycline), cisplatin (platinum compound) and cyclophosphamide (alkylating agent). Holes were observed in cells exposed to SMF but not in control groups. The number, size and shape of the holes were dependent on the drug type, SMF parameters and the duration of exposure. The results suggest that the application of a SMF could alter membrane permeability, increasing the flow of the anticancer drugs. This may be one of the reasons why SMF can strengthen the effect of anticancer drugs. Observations were also made of the effect of using different anticancer drugs. For example, the effect of SMF combined with taxol or cyclophosphamide on the cells was additive while the effect of SMF combined with cisplatin or doxorubicin was synergistic. The target sites of cisplatin and doxorubicin are nucleic acids; continued research is required into this important area to ascertain the effect of SMF on nucleic acids.
- 1 May 2011
- Published by SAGE Publications in Tumori Journal
- Vol. 97 (3) , 386-392
An investigation into the combined effect of static magnetic fields and different anticancer drugs on K562 cell membranes
Aims and background: Cell membranes were shown to be sensitive to and affected by static magnetic fields (SMF). Methods: Cells were treated with four anticancer drugs followed by treatment with a combination of drugs and SMF. Individual cells were examined using atomic force microscopy (AFM). The drugs were taxol (alkaloid), doxorubicin (anthracycline), cisplatin (platinum compound) and cyclophosphamide (alkylating agent). Results: Holes were observed in cells exposed to SMF but not in control groups. The number, size and shape of the holes were dependent on the drug type, SMF parameters and the duration of exposure. Conclusions: The results suggest that the application of a SMF could alter membrane permeability, increasing the flow of the anticancer drugs. This may be one of the reasons why SMF can strengthen the effect of anticancer drugs. Observations were also made of the effect of using different anticancer drugs. For example, the effect of SMF combined with taxol or cyclophosphamide on the cells was additive while the effect of SMF combined with cisplatin or doxorubicin was synergistic. The target sites of cisplatin and doxorubicin are nucleic acids; continued research is required into this important area to ascertain the effect of SMF on nucleic acids.
- 1 May 2011
- Published by SAGE Publications in Tumori Journal
- Vol. 97 (3) , 386-392
An investigation into the combined effect of static magnetic fields and different anticancer drugs on K562 cell membranes
Aims and background: Cell membranes were shown to be sensitive to and affected by static magnetic fields (SMF). Methods: Cells were treated with four anticancer drugs followed by treatment with a combination of drugs and SMF. Individual cells were examined using atomic force microscopy (AFM). The drugs were taxol (alkaloid), doxorubicin (anthracycline), cisplatin (platinum compound) and cyclophosphamide (alkylating agent). Results: Holes were observed in cells exposed to SMF but not in control groups. The number, size and shape of the holes were dependent on the drug type, SMF parameters and the duration of exposure. Conclusions: The results suggest that the application of a SMF could alter membrane permeability, increasing the flow of the anticancer drugs. This may be one of the reasons why SMF can strengthen the effect of anticancer drugs. Observations were also made of the effect of using different anticancer drugs. For example, the effect of SMF combined with taxol or cyclophosphamide on the cells was additive while the effect of SMF combined with cisplatin or doxorubicin was synergistic. The target sites of cisplatin and doxorubicin are nucleic acids; continued research is required into this important area to ascertain the effect of SMF on nucleic acids.